Holger L.
- Country
- Germany
- Department
- Universitätsklinikum Tübingen, Abteilung Neurologie mit Schwerpunkt Epileptologie
Research Overview
- A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Subjects Diagnosed With Epilepsy (X-TOLE4)
- Evaluation of the Safety, Tolerability, and Efficacy of Azetukalner as Adjunctive Therapy in Adults with Focal-Onset Epilepsy: A Randomized, Double-Blind, Placebo-Controlled Study
- A Randomized, Double-blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures (X-ACKT)
Data & Insights
Has run more than one trial at 54 of 84 partner sites.
Specializations
Epilepsy Management
The investigator specializes in the treatment of various forms of epilepsy, with particular emphasis on both focal-onset seizures and primary generalized tonic-clonic seizures (PGTCS).
- Adult Focal Epilepsy
- Primary Generalized Seizures
- Complex Seizure Disorders
Their research focuses on developing therapeutic approaches for patients with drug-resistant epilepsy forms.
Neurological Therapeutics
The investigator concentrates on evaluating novel therapeutic interventions for neurological disorders, particularly in cases where standard treatments may have limited efficacy.
- Antiseizure Medication Assessment
- Long-term Treatment Strategies
- Additional Therapy Approaches
Their work encompasses the evaluation of innovative treatment options for patients with varying seizure types.
Clinical Assessment
The investigator's expertise extends to comprehensive clinical evaluation of therapeutic interventions, focusing on both efficacy and safety parameters in epilepsy treatment.
- Treatment Safety Analysis
- Seizure Frequency Assessment
- Therapeutic Tolerance Studies
Their research involves systematic evaluation of treatment outcomes in various seizure disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.